Protecting Patients from Deceptive Drug Ads Online Act

S 5040, the "Protecting Patients from Deceptive Drug Ads Online Act," targets false or misleading online promotions of prescription drugs by social media influencers and healthcare providers. It requires these individuals to include clear summaries of side effects, contraindications, and effectiveness in their posts - similar to requirements for traditional drug ads - and imposes civil penalties for violations involving knowingly false claims or material omissions. The bill also mandates new reporting for payments between drug manufacturers, healthcare providers, and influencers related to drug promotion, and directs the FDA to issue guidance on enforcement within 180 days. These changes apply to all prescription drugs covered under Medicare or Medicaid, aiming to improve transparency and safety in digital drug advertising.